No improvement in overall survival (OS) was observed with palbociclib (Verzenio) plus endocrine therapy versus capecitabine ...

It was a Novartis ad with comedian Wanda Sykes, who, alongside MCU actress Hailee Steinfield, spoke about the importance of ...

Novartis looks odds on to extend the indications of its CDK4/6 inhibitor Kisqali into early-stage breast cancer, on the back of data from the phase 3 NATALEE trial reported at the ASCO congress.

NICE has recommended moving Novartis’ Kisqali (ribociclib) from interim funding arrangements to regular NHS reimbursement for certain previously treated breast cancer patients. In the final ...

Comedian Wanda Sykes faced breast cancer with humor, opting for a double mastectomy. She now advocates for early detection, ...

Health insurers no longer completely cover two breast cancer drugs for women with metastasised hormone ... different effectiveness and side effects of the three drugs, she said. Novartis, the makers ...

One of Monte Rosa's main differentiating factors is its proprietary QuEEN platform to design new molecular glue degraders.

Novartis has committed $7.5 million to an initiative aiming to save 100,000 lives by 2035. The money will launch Zero ...

A new study led by a George Washington University Cancer Center researcher found that cold therapy protects breast cancer ...

San Antonio Breast Cancer Symposium 2024 provided multiple updates in the field of HER2-positive breast cancer, including novel treatments, new treatment regimens and more.See Healio’s highlights in H ...